MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

21st International Congress » Epidemiology

Date: Monday, June 5, 2017

Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:45pm-3:15pm
Demographic and Clinical Characters of Parkinson’s Disease in Tertiary Hospital in Kuwait

W. Kamel, J. Al Hashel, S. Ahmed (Kuwait, Kuwait)

1:45pm-3:15pm
Integration of risk factors for PD in two large longitudinal cohorts

I. Kim, E. O'Reilly, K. Hughes, X. Gao, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

1:45pm-3:15pm
Analyses of physical activity on cognitive flexibility, depression and RBD in healthy elderly with high risk for neurodegenerative diseases

S. Lerche, A. Gutfreund, K. Brockmann, I. Wurster, G. Eschweiler, F. Metzger, W. Maetzler, D. Berg (Tuebingen, Germany)

1:45pm-3:15pm
Analysis of related factors of occurrence of dementia in Parkinson’s disease using the application form of Parkinson’s disease provided by the specific diseases treatment research program of Ministry of Health, Labor and Welfare of Japan

K. Konaka, M. Mihara, H. Mochizuki (Suita, Japan)

1:45pm-3:15pm
Associations of probable REM sleep behavior disorder, constipation, and hyposmia with PD

K. Hughes, X. Gao, J. Baker, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

1:45pm-3:15pm
Body mass index, change in body mass index and risk of Parkinson`s disease

J. Lee, J.H. Kim, J.H. Cho, G.S. Kim, J.H. Lee, P.H. Lee, Y.H. Sohn (Goyang-shi, Republic of Korea)

1:45pm-3:15pm
Calcium Channel Blocking Drugs and Risk of LRRK2 Parkinson’s Disease

C. Marras, K. Marder, R. Alcalay, R. Saunders-Pullman, C. Meng, S. Goldman, A. Lang, M. Korell, M. San Luciano, E. Tolosa, B. Schuele, A. Brice, S. Goldwurm, G. Riboldazzi, C. Klein, G. Mellick, C. Sue, E.K. Tan, K. Brockmann, K. Hasegawa, S. Bressman, J. Ferreira, M. Tazir, W. Langston, D. Berg, C. Tanner (Toronto, ON, Canada)

1:45pm-3:15pm
Examining the brain reserve hypothesis in Parkinson’s disease

P.C. Lee, F. Artaud, F. Cormier, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, F. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, V. Mesnage, A. Brice, M. Vidailhet, J.-C. Corvol, A. Elbaz (Taipei, Taiwan)

1:45pm-3:15pm
Experience and outcomes of the first Movement Disorders Clinic in Honduras.

J. Ortiz, A. Medina, F. Naranjo (Tegucigalpa, Honduras)

1:45pm-3:15pm
General Anesthesia and Parkinson’s Disease

C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)

1:45pm-3:15pm
Helicobacter pylori eradication and risk of Parkinson’s disease in patients with peptic ulcers

Y.-P. Chang, G.-F. Chiu, Y.-H. Chang, D.-C. Wu (Kaohsiung, Taiwan)

1:45pm-3:15pm
Increased BMI May Protect Against Parkinson’s Disease: Evidence From A Mendelian Randomisation Study

A. Noyce, D. Kia, G. Hemani, A. Nicolas, T. Price, E. Fernandez, P. Haycock, P. Lewis, T. Foltynie, G. Davey Smith, A. Schrag, A. Lees, J. Hardy, A. Singleton, M. Nalls, N. Pearce, D. Lawlor, N. Wood (London, United Kingdom)

1:45pm-3:15pm
Influence of major earthquakes and their effects on patients with Parkinson’s disease: A multi-institutional study

R. Kurisaki, H. Ueyama, Y. Maeda, T. Sakamoto, K. Nakahara, S. Nakane, S. Yamashita, Y. Ando (Koshi, Japan)

1:45pm-3:15pm
Is Hypertension and Certain Anti Hypertensive Agents Increase The Risk of Parkinson Disease?

R. Pinzon (Yogyakarta, Indonesia)

1:45pm-3:15pm
MDS prodromal PD research criteria validation in two independent prospective cohorts

A. Pilotto, S. Heinzel, U. Suenkel, S. Lerche, K. Brockmann, b. Roeben, E. Schaeffer, i. Wurster, R. Yilmaz, I. Liepelt-Scarfone, A. von Thaler, F. Metzger, g. Eschweiler, R. Postuma, W. Maetzler, D. Berg (Tuebingen, Germany)

1:45pm-3:15pm
Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

R. Hoque (Dhaka, Bangladesh)

1:45pm-3:15pm
Occupational trichloroethylene exposure and Parkinson’s disease risk

S. Goldman, P. Quinlan, C. Meng, K. Comyns, G.W. Ross, K. Marek, C. Tanner (San Francisco, CA, USA)

1:45pm-3:15pm
Oral health-related quality of life and dental care among Parkinson’s disease patients and Care givers of South India.

E. Aluckal (Ernakulam, India)

1:45pm-3:15pm
Research participants are not representative of the population age distribution of PD

A. Macleod, R. Henery, P. Nwajiugo, C. Counsell (Aberdeen, United Kingdom)

1:45pm-3:15pm
Serum cholesterol levels over time and risk of Parkinson’s disease

V. Rozani, T. Gurevich, N. Giladi, B. El-Ad, J. Tsamir, B. Hemo, C. Peretz (Tel A viv, Israel)

1:45pm-3:15pm
Sex Differences in Homebound Advanced Parkinson’s Disease Patients

L. Nwabuobi, W. Barbosa, M. Sweeney, S. Oyler, A. Lemen, T. Meisel, A. Di Rocco, J. Chodosh, J. Fleisher (New York, NY, USA)

1:45pm-3:15pm
The Life Style and Risk of Parkinson Disease

R. Pinzon (Yogyakarta, Indonesia)

1:45pm-3:15pm
The Roles of Diet, Exercise, & Supplements in Parkinson’s Disease Progression

L. Mischley, R. Lau (Kenmore, WA, USA)

1:45pm-3:15pm
The SYNAPSES study  (StudY to observe SafiNAmide in clinical Practice during the firSt post-commErcialization phaSe): methodology and results from the European feasibility survey

G. Camattari, G. Abbruzzese, W. Jost, J. Kulisevsky, V. Tubazio, L. Simoni, The SYNAPSES investigators (Bresso, Italy)

1:45pm-3:15pm
The value of various risk factors in the manifestation of Parkinson’s disease in the southern part of Uzbekistan.

S. Lukmonov (Tashkent, Uzbekistan)

1:45pm-3:15pm
Tonsillectomy and risk of Parkinson’s disease: A Danish nationwide population-based cohort study

E. Svensson, V. Henderson, S. Szépligeti, M. Stokholm, T. Klug, H. Sørensen, P. Borghammer (Aarhus, Denmark)

1:45pm-3:15pm
Tremor-Dominant Clinical Phenotype is Associated with Low Risk of Levodopa-Induced Dyskinesia in Parkinson’s Disease

B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)

1:45pm-3:15pm
Two ethnic clusters with Huntington’s disease in Israel – The case of Mountain Jews and Karaites

J. Zitser, A. Thaler, N. Inbar, S. Naor, N. Giladi, T. Gurevich (Tel Aviv, Israel)

1:45pm-3:15pm
Vascular Parkinsonism, an underdiagnosed Parkinsonian variant : An outpatient study from a South Indian Superspeciality Private Hospital

S. Jaiswal, M. Reddy (Hyderabad, India)

« View all sessions from the 21st International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley